D-0798-2021 Class III Terminated
FDA drug recall D-0798-2021 was initiated by Viatris on Sep 13, 2021 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; out of specification for Related Compound The recall status is terminated (terminated Apr 28, 2022). Affected quantity: 21,094.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 22, 2021
- Initiation Date
- Sep 13, 2021
- Termination Date
- Apr 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 21,094
Product description
Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93
Reason for recall
Failed Impurities/Degradation Specifications; out of specification for Related Compound
Distribution pattern
Product was distributed nationwide.
Code information
Lot # 3107334, exp. date October 2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0798-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026